Karen Starback

Karen Starback has extensive work experience in the pharmaceutical industry, primarily focused on quality assurance and compliance. Karen'smost recent position was as the Head of GCP Quality Assurance at Amunix Pharmaceuticals, a role they began in January 2023. Prior to that, they served as the Director of Quality Assurance, GCP at Olema Oncology from May 2021 to August 2022.

Karen also held positions at BioMarin, starting as a Sr. Assessment Manager, GCP Quality Assurance in March 2020 and concluding in May 2021. Before that, they worked as a Clinical Research Consultant at Starback Consulting from April 2014 to March 2020.

Earlier in their career, Karen held various roles at Genentech. Karen was a Senior International Compliance Auditor from May 2012 to April 2014, a Global Studies Leader from October 2010 to May 2012, a Senior Compliance Auditor from 2008 to 2010, and a Clinical Scientist Specialist Consultant from 2007 to 2008.

Additionally, Karen has experience as a GCP QA Consultant at Oxigene Inc. in 2007 and as a Sr. Manager Training and SOPs at BioMarin Pharmaceutical Inc. in 2006.

Karen Starback attended The Ohio State University. It is not specified when they started or finished their education, and there is no information regarding the degree or field of study they pursued.